Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I (GSD-DIET)

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The present project will specifically assess metabolic effects of dietary interventions with controlled intake of fructose and fructose/galactose in GSDI, with the aim to provide evidence whether relaxed dietary restrictions of fructose and galactose may be justified in treatment recommendations at least for adults, which would considerably enlarge food choice in everyday life of the patients with an expected positive impact on the quality of life of patients with this rare disorder.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Genetically and/or enzymatically confirmed diagnosis of GSDI (GSDIa or GSDIb)

• Male or female ≥ 18y

• Restriction of fructose intake in usual dietary treatment

• Written informed consent

Locations
Other Locations
Switzerland
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital
RECRUITING
Bern
Contact Information
Primary
Michel Hochuli, MD, PhD
michel.hochuli@insel.ch
+41 31 664 03 18
Time Frame
Start Date: 2025-04-24
Estimated Completion Date: 2027-03
Participants
Target number of participants: 20
Treatments
Experimental: Diet with additional fructose intake
Experimental: Diet with additional fructose and galactose intake
Related Therapeutic Areas
Sponsors
Collaborators: Medical University Innsbruck, University Hospital Freiburg, University of Zurich, University Hospital Heidelberg
Leads: Insel Gruppe AG, University Hospital Bern

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.